Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies.
Roberto VisentinMichele SchiavonClemens GiegerichThomas KlabundeChiara Dalla ManClaudio CobelliPublished in: IEEE Trans. Biomed. Eng. (2019)